Auron Therapeutics

Newton, MA · Founded 2018 · Privately Held (backing)

Operator of a biotechnology company intended to research and develop products focusing on the immunology and oncology medical fields. Auron Therapeutics is based in Newton, MA and was founded in 2018. It was valued at $106 million at its later-stage round in Dec 2025, the last priced event on record. It has raised $90.7 million across 4 recorded rounds; the latest was a $27.3 million early-stage round in Dec 2024.

PMV mark · valuation
$106.3M
Oct 2026
Priced at
its later-stage round
Dec 2025
Total raised
$90.7M
Last round
Early Stage VC
Dec 2024

Who backs Auron Therapeutics?

15 investors
InvestorType
Qiming Venture Partners USAVenture capital
DCVCVenture capital
Polaris PartnersVenture capital
Arkin CapitalFamily office
Casdin CapitalVenture capital
Mubadala CapitalAsset manager
DCVC BioVenture capital
BrightEdgeVenture capital
ACS BrightEdge—
Apollo Health Ventures—
+ 5 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Auron Therapeutics investors

15 investors are on record for Auron Therapeutics, including Qiming Venture Partners USA, DCVC, Polaris Partners and Arkin Capital. By type, the record holds 6 venture capital firms, 1 family office and 1 asset manager. The early-stage round in Dec 2024 drew 16 investors.

Free account
More of Auron Therapeutics with a free account
  • ·The complete investor list: 15 names
  • ·Watch Auron Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 15 firms already write checks for companies like Auron Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View